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Abstract
Heterochromatinisation of pericentromeres, which in mice consist of arrays of major satel-
lite repeats, are important for centromere formation and maintenance of genome stability.
The dysregulation of this process has been linked to genomic stress and various cancers.
Here we show in mice that the proteasome binds to major satellite repeats and proteasome
inhibition by MG132 results in their transcriptional de-repression; this de-repression is inde-
pendent of cell-cycle perturbation. The transcriptional activation of major satellite repeats
upon proteasome inhibition is accompanied by delocalisation of heterochromatin protein 1
alpha (HP1α) from chromocentres, without detectable change in the levels of histone
H3K9me3, H3K4me3, H3K36me3 and H3 acetylation on the major satellite repeats. More-
over, inhibition of the proteasome was found to increase the number of chromocentres per
cell, reflecting destabilisation of the chromocentre structures. Our findings suggest that the
proteasome plays a role in maintaining heterochromatin integrity of pericentromeres.
Introduction
Packaging of DNA into chromatin plays an important role in transcriptional regulation.
Euchromatin is accessible to the transcriptionmachinerywhereas heterochromatin is more
compact and associated with transcriptional repression [1]. Multiple factors including tran-
scription factors, post-translational histone modifications and DNA methylation are thought
to maintain heterochromatin repression [2]. Among them, histone hypoacetylation, histone 3
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lysine 9 trimethylation (H3K9me3) and heterochromatin protein 1 (HP1α) were shown to be
required for maintenance of heterochromatin [3, 4]. Constitutive heterochromatin predomi-
nantly consists of satellite repeats. In mouse cells, pericentromeric and centromeric satellite
repeats are the major and minor satellite repeats respectively [5]. Heterochromatinisation of
pericentromeric repeats is important for centromere formation and maintenance of genome
stability [6]. Low levels of pericentromeric satellite repeat transcription have been detected
under various physiological conditions, including cell cycle, senescence, development and dif-
ferentiation [7–10]. However, aberrant overexpression of pericentromeric satellite repeats has
been detected in several pathological conditions, including cellular stress [11–13], cancer [14–
17] and some genetic disorders [18–20].
The proteasome is a highly conservedproteolytic complex comprised of the catalytic 20S
core particle (CP) capped at one or both ends by the 19s regulatory particle (RP). It regulates
protein quality by recognising, unfolding and degrading polyubiquitin tagged, aged, misfolded
or damaged proteins [21–23]. Growing evidence,mainly from studies in yeast, suggests that
the proteasome is associated with chromatin and regulates transcription [24–30]. Thus, the
proteasome regulates the levels and binding of activators as well as recruitment of co-activators
at 5’ regulatory regions, thereby controlling transcriptional initiation [26, 31, 32] as well as
elongation [27, 33]. It is also thought to enable release of RNA polymerase II (RNAPII) and
thereby regulate transcription termination [34]. Moreover, defects of the proteasome subunits
in yeast were shown to enhance transcriptional repression of heterochromatin [35]. Addition-
ally, ubiquitin mediated degradation of the Jmj family protein Epe1 was shown to be required
for the accurate formation of heterochromatin boundaries [36]. Notably, few studies, mostly in
mammalian cells, suggest that the proteasome also regulates transcriptional repression. For
example, inhibition of the 20S proteasome resulted in increased levels of RNAPII and the active
chromatin mark H3K4me3 at the glucocorticoid responsive gene promoter, where proteasome
binding was identified in human cells [37]. Another study proposed that the proteasome blocks
nonspecific transcription initiation by preventing formation of the preinitiation complex at
cryptic transcription sites [38] and degrades RNAPII or a member of the pre-initiation com-
plex that drives the transcription at these ectopic sites, thereby suppressing transcription.
Moreover, a study performed on rat liver showed that proteasome inhibition led to global his-
tone hypomethylation (especially at H3K9 and H3K27 residues) and hyperacetylation [39].
Here we demonstrate that proteasomal activity in mice is also involved in the repression of
pericentromeric satellite repeat expression and integrity of pericentromeric clusters.
Results and Discussion
Binding of the 20S proteasome at major satellite repeats
Several studies have shown the presence of the proteasome in eukaryotic nuclei [40–44] and its
recruitment to chromatin including centromeres [45], telomeres [46] and sites of cryptic tran-
scriptional initiation [38]. To investigate whether the proteasome might participate in tran-
scriptional silencing of heterochromatin, proteasome binding at pericentromeric and several
other endogenous repeats was analysed using ChIP-seq data previously obtained in mouse
3T3-L1 cells [47]. The results indicated a ~1.2 fold enrichment of the proteasome at pericentro-
meric major satellite repeats and LINE L1 elements and ~1.9 fold enrichment at centromeric
minor satellite repeats, compared to input, whereas all other elements showed no signal above
input (Fig 1A). To replicate this qualitative observation,ChIP was performed in another
mouse NIH3T3 cell line using an antibody against the 20S proteasome which confirmed bind-
ing of the 20S proteasome to major satellite repeats as well as to LINE L1 elements (Fig 1B).
The signal fromminor satellite was relatively low and close to background, as was the case for
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the ChIP-seq data, making it difficult to be precise about the extent of enrichment in this
location.
Transcriptional activation of major satellite repeats expression upon
proteasome inhibition
To assess the role of the proteasome at major satellite repeats, pericentromeric transcription
was assessed in NIH3T3 cells treated with a widely used and specific proteasome inhibitor
Fig 1. Binding of the 20S proteasome particle at major satellite repeats. (A) ChIP-seq data analysis
obtained by ChIP against FLAG-tagged β1 subunit (PSMB1) of the 20S proteasome particle in the mouse
3T3-L1 cell line. The enrichment was greater at major and minor satellites as well as LINE_L1 elements but
not other classes of DNA repetitive elements. (B) ChIP-qPCR analysis using antibody against β6 subunit of
the 20S proteasome and no antibody control performed on the mouse NIH3T3 cell line. Enrichment level is
shown relative to input after subtraction of background. Error bars = SEM of 3 biological replicate.
doi:10.1371/journal.pone.0165873.g001
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MG132. A dose-dependent increase in transcript level of major satellite repeat was observed
uponMG132 treatment, reaching 10-fold in treated cells when compared to dimethyl sulfoxide
(DMSO—vehicle) (Fig 2A), whereas no effect was seen on the minor satellite expression (Fig
2A). The increase in the major satellite transcript levels could be due to an increase in tran-
scription or to inhibition of major satellite transcript degradation. To assess whether transcrip-
tion was required for the increase in major satellite repeats transcripts, cells were treated with
the transcriptional inhibitor Actinomycin D (ActD) concomitant with MG132. Transcription
was effectively inhibited (Fig 2B) and the increase of the major satellite repeat transcription
upon proteasome inhibition was blocked in cells treated concomitantly with bothMG132 and
ActD (Fig 2B), indicating that their upregulation in response to MG132 was indeed transcrip-
tion dependent. This was further validated at the single cell level using RNA fluorescent in situ
hybridization (RNA FISH) targeting major satellite transcripts. Proteasome inhibition led to an
Fig 2. Proteasome inhibition results in upregulation of major satellite repeat expression which is dependent on transcription. (A) Dose-
dependent upregulation of major satellite repeat expression upon proteasome inhibition NIH3T3 cells were treated with 5μM, 10μM and 20μM
MG132 for 8h and transcript levels of major satellite and minor satellite were measured by q-RT-PCR. The relative expression was normalised against
spiked RNA and shows fold change relative to DMSO (vehicle). Error bars = SEM of 6 biological replicates. (B) Transcription-dependent
upregulation of major satellite repeat expression upon proteasome inhibition. Kinetics of the effect of the proteasome inhibition and/or RNAPII
inhibition on the expression of major satellite repeats. The right graph indicates the efficiency of the transcriptional inhibition measured by decay of the
c-MYC and major transcripts. The exponential decay curve was obtained using best fitted nonlinear regression model. NIH3T3 cells were treated with
either 20μM MG132, 20μg/ml ActD or both 20μg/ml ActD and 20μM MG132 for 1h, 2h, 4h and 8h followed by RNA extraction and q-RT-PCR. The
relative expression was normalised against spiked RNA or Gapdh and shows fold change relative to DMSO. Error bars = SEM of 3 biological replicates.
(C) RNA FISH imaging of major satellite repeat transcription upon proteasome inhibition NIH3T3 cells were treated with 20μM M132 for 2h and
4h followed by RNA-FISH analysis using major satellite probe. Representative mid-zone confocal z-sections images for DAPI (blue), major (red) and
merge are shown for 2h and 4h with DMSO and MG132 treatment. Scale bar 2μm. * p<0.05, ** p<0.001 (Student’s ‘t’ test).
doi:10.1371/journal.pone.0165873.g002
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increase in the major satellite repeat expression in MG132 treated cells for 4h (Fig 2C). Major
satellite signal was located surrounding or within a proportion of DAPI-dense heterochroma-
tin regions showing the characteristicmorphology of chromocentres [48]. Signal was also iden-
tified in areas of the nucleus lacking chromocentres suggesting either partial transcription from
intergenic major satellite DNA sequences or migration of the transcript away from the chro-
mocentres (Fig 2C). Thus, the RNA-FISH analysis is consistent with the previous observation
that major satellite repeat transcription was upregulated upon proteasome inhibition (Fig 2A
and 2B).
Upregulation of major satellite repeats upon proteasome inhibition
occurs independently of cell cycle perturbation
Considering that (i) proteasome inhibition induces cell-cycle arrest in various cell types [49–
52] and (ii) cell cycle was shown to regulate the transcription of both pericentromeric and cen-
tromeric satellite repeats [7, 53], it was necessary to determine whether the transcriptional acti-
vation of major satellite repeats was due to cell cycle skewing. To confirm the cell-cycle
dependent transcription of major and minor satellite repeats, counterflow centrifugal elutria-
tion [54] was performed for cell synchronization. Elutriation offers the advantage of selection
of cells in different stages of cell cycle and, unlike chemical agents, does not affect the metabo-
lism of cells [54]. The expression of major and minor satellite repeats peaked in G1 and G2/M
phases of the cell cycle respectively (S1 Fig), consistent with previous published studies (Ferri
et al., 2009; Lu and Gilbert, 2007). We next investigated the effect of proteasome inhibition on
(i) the kinetics of transcriptional activation of major and minor satellite repeats and (ii) the cell
cycle. Interestingly, the kinetic analysis showed an upregulation of the major satellite repeat
expression already at 4h after MG132 treatment (Fig 3A), the time point where no significant
effect was seen on the cell cycle profile (Fig 3B). As previously, minor satellite repeat expression
was unaffected (Fig 3A). Taken together, these results suggest that upregulation of major satel-
lite repeat expression upon proteasome inhibition is unlikely to be a consequence of cell cycle
skewing because the upregulation of the major satellite repeat expression occurredwithout any
significant effects on the cell cycle distribution.
The effect of proteasome inhibition on chromatin structure
To assess whether the major satellite repeat upregulation was accompanied by an alteration in
the chromatin, histone modifications including H3 acetylation, H3K9me3, H3K4me3 and
H3K36me3 were analysed by ChIP-qPCR after treatment of NIH3T3 cells with MG132.
H3K9me3, which is considered a “hallmark” of heterochromatin [55] was found to be unaf-
fected by MG132 treatment (Fig 4A). This was further confirmed by immunofluorescence (IF)
(Fig 4B). Similar to H3K9me3, the levels of H3 acetylation, H3K4me3 (which is normally asso-
ciated with promoters of actively transcribed genes [56, 57]) and H3K36me3 (which is nor-
mally associated with elongating RNAPII [58, 59]) were found to be similar between cells
treated with MG132 and untreated (DMSO) cells (Fig 4A). Thus, the ChIP-qPCR results sug-
gest that proteasome inhibition does not have any net effect on these histone modifications at
the major satellite repeat locus. The lack of effectmight seem surprising given that proteasome
inhibition led to significantly increased transcription of the repeats. This may relate to the pro-
portion of repeat sequences that have been activated by inhibiting the proteasome. The RNA
FISH experiment indicates that the number of repeats or heterochromatic clusters that are
transcriptionally activated might be a small proportion of the total and therefore any chroma-
tin change would be diluted by the majority of DNA sequences which are not expressing the
transcript. This lack of effect on H3K9me3 has been observed in several previous studies
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PLOS ONE | DOI:10.1371/journal.pone.0165873 November 2, 2016 5 / 18
Fig 3. Proteasome inhibition upregulates the major satellite transcription before any significant effect on the cell cycle
distribution. (A) Kinetics of expression of major and minor satellite repeats upon proteasome inhibition. NIH3T3 cells
were treated with 20μM MG132 for 1h, 2h and 4h followed by RNA extraction and q-RT-PCR. The relative expression was
normalised against spike and shows fold change relative DMSO. Error bars = SEM of at least 10 biological replicates.
Proteasome inhibition upregulated the major satellite repeat expression at 4h of treatment, while minor satellite remained
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(Mosch et al., 2011; Zhu et al., 2011 and see discussion below) where major satellite repeats
were found to be upregulated to a similar degree. In contrast, in Pax3/Pax9 deficient iMEFs
[60] there was a more significant increase in major satellite transcription and a clear loss of
H3K9me3. Lastly, Zhang et al, have similarly reported that transcriptional activation of silent
heterochromatin in yeast can occur without any significant changes in the histone modifica-
tions [61]. Heterochromatin at pericentromeres is not only regulated by histone modification
but also by structural proteins such as HP1α which are involved in chromatin condensation
and maintenance of stable heterochromatin [62, 63]. Therefore, the effect of proteasome inhi-
bition on the localisation and distribution of HP1α was evaluated by IF after treatment of
NIH3T3 cells with proteasome inhibitor. As expected, in the untreated cells (DMSO), HP1α
was concentrated in the DAPI dense stained regions, confirming its localisation to pericentro-
meric heterochromatin. Interestingly, MG132 treatment resulted in a dispersed distribution of
the HP1α protein throughout the nucleus, (Fig 4C and S2A Fig) however, total HP1α levels
remained similar between treated and untreated cells (S2B Fig). Thus, proteasome inhibition
led to displacement of HP1α from chromocentres, without visible changes in the DAPI dense
staining domains. Whether HP1α is displaced specifically from pericentromeric heterochro-
matin (or from other repressed genomic loci that are associated with chromocentres) remains
to be shown. Furthermore this observation is consistent with previous studies where loss of
HP1 from pericentromeric heterochromatin was not sufficient to disrupt the DAPI dense
stained regions or H3K9me3 [64, 65]. It is also in line with previous reports [64, 66], where
transcriptional activation of pericentromeric repeats was accompanied by either partial or full
displacement of HP1 from pericentromeres without any changes in H3K9me3 levels, the latter
of which serves as a platform for HP1 recruitment to chromatin [67, 68]. Also, HP1α/β double
knockout in MEF cells led to upregulation of major satellite repeat expression without affecting
the localization of H3K9me3 [64]. Another example comes from BRCA1-deficient cells, where
a significant reduction in the number of HP1 positive foci and loss of ubiquitylation of histone
H2A (H2Aub) was reported to result in activation of major and minor satellite repeat tran-
scription [66]. Lastly, mutation of variant H3.3 at an early stage in development resulted in
increased accumulation of major satellite repeat transcripts which was accompanied by dis-
placement of HP1 from chromocentres [69]. Therefore, it is tempting to speculate that dissoci-
ation of HP1α, as seen here, could be sufficient for the remodelling of heterochromatin
rendering it accessible to the transcriptional machinery.
The immunofluorescence imaging of chromocentres (visualised by DAPI) after treatment
with proteasome inhibitor did not reveal any obvious structural changes (Fig 4C). Considering
that (i) major satellite repeats reside at these regions and (ii) a previous study suggested that
upregulation of major satellite repeat expression was accompanied by a marked decrease in the
number of chromocentres [66], here the number of chromocentres was analysed in NIH3T3
cells after proteasome inhibition. To acquire cells in a high-throughput manner, an imaging
flow cytometer (ImageStream X) was used. Cells were treated with either DMSO or MG132,
followed by staining with DRAQ5, which is less toxic for living cells compared to DAPI [70].
Treatment of cells with MG132 resulted in a shift of the distribution of the number of chromo-
centres per cell towards the right (Fig 5), which increasedwith time. It is possible that the
increased number of chromocentres per cell after proteasome inhibition might result from
unaffected. (B) Treatment of cells with proteasome inhibitor MG132 for 4h does not significantly alter the distribution of
the cell cycle profile. NIH3T3 cells were treated with DMSO or 20μM MG132 for 1h, 2h and 4h followed by PI staining and
FACS analysis. Proportion (%) of acquired cells in G1/G0, S and G2/M phases are shown for treated and untreated cells.
*p<0.05 (Student’s ‘t’ test).
doi:10.1371/journal.pone.0165873.g003
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Fig 4. HP1α delocalises from chromocentres upon proteasome inhibition whereas the histone modifications remain unaffected. (A)
Proteasome inhibition does not affect canonical histone modifications on major and minor satellite repeats. NIH3T3 cells were treated with
20μM MG132 for 4h followed by ChIP–qPCR analysis using antibodies against repressive mark H3K9me3 and activating marks H3K4me3, H3K36me3,
and H3ac. Data is shown as relative enrichment to H3 with background subtraction. The y-axis scale was adjusted depending on the signal obtained with
different antibodies. Error bars = SEM of 3 biological replicates. (B) Proteasome inhibition does not affect H3K9me3. NIH3T3 cells were treated with
20μM MG132 for 4h and immunolabeled with H3K9me3 antibody (red) and stained with DAPI (blue). Scale bar 10μm. (C) Delocalisation of HP1α from
Proteasome Inhibition Disrupts Heterochromatin
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eviction of HP1α and destabilisation of chromocentre structure, which in turn could reduce
the compaction of heterochromatin and increase accessibility of the transcriptional machinery
to the underlying DNA sequences.
Conclusion
The molecular link between the dysregulation of satellite transcription and genomic stress
(Zhu et al., 2011) as well as cancer (Eymery et al., 2009) could open a new avenue for under-
standing cancer evolution and the design of new therapeutic approaches. Here we showed the
binding of proteasome to major satellite repeats and their dysregulation upon proteasome inhi-
bition by MG132. As the proteasome participates in a large number of cellular pathways and
controls the steady-state level of many proteins, it is difficult to distinguish between direct
involvement of the proteasome on the transcription of the pericentromeric repeat and indirect
chromocentres upon proteasome inhibition. NIH3T3 cells were treated with 20μM MG132 for 4h and immunolabeled with HP1α antibody (green) and
co-stained with DAPI (blue). Scale bar 10μm.
doi:10.1371/journal.pone.0165873.g004
Fig 5. Proteasome inhibition increases the number of chromocentres per cell. NIH3T3 cells were treated with DMSO (vehicle) or 20μM MG132
for 2h and 4h followed by DRAQ5 staining and imaging using ImageStreamX. (A) Representative images from brightfield and DRAQ5 wavelengths for
each time point of the treatment. DRAQ5 identified chromocentres. (B) Comparison of the distribution of the number of chromocentres per cell upon
treatment with MG132 and DMSO for each time point (Chi-squared P<0.0001 at both 2 and 4h). Error bars = SEM of 3 biological replicates.
doi:10.1371/journal.pone.0165873.g005
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effectsmediated by a protein whose level is controlled by proteasome activity. Several studies
have shown that the proteasome degrades stalled RNAPII during transcription-coupled repair
[71, 72] and a similar mechanism could potentially operate at major satellite repeats. At peri-
centromeric repeats the proteasome might function to degrade RNAPII and thereby prevent
their expression. Additionally, accumulation of misfolded proteins due to proteasome inhibi-
tion is known to trigger cell stress responses [73–80]. Therefore, a component from the cell
stress pathway might also be responsible for the de-repression of the major satellite repeat. For
example, HSF1 was previously shown to activate the transcription of pericentromeric Satellite
II and III repeats in human cells upon heat shock in order to form nuclear stress bodies [13, 81,
82]; this effect was reported to be human-specific (Valgardsdottir et al., 2008), but similar fac-
tors may play a role in other mammals. It is interesting that the eviction of HP1 and disaggre-
gation of chromocentres shown here precedes the detection of major satellite transcripts
suggesting that the proteasome is required for integrity of heterochromatin.
Materials and Methods
Cell line
NIH3T3 cell line was maintained in Dulbecco’s modifiedEagle’s medium (DMEM) with L-glu-
tamine (PAA laboratories GmbH) supplemented with Foetal bovine serum (Sigma) (10% v/v),
Penicillin/Streptomycin (GIBCO1) (1% v/v) and GlutamixTM-I 100x (GIBCO1) (1% v/v) at
37°C in 5% CO2. Cells were treated with MG132 (Sigma) which was dissolved in DMSO; ActD
(Sigma) which was dissolved in DMSO.
Quantitative Reverse Transcription Coupled to PCR
After RNA isolation using TRIZOL1 Reagent (Invitrogen) and genomic DNA digestion with a
DNA free kit (Ambion), cDNA was synthesized using ThermoScript kit (Invitrogen) and ran-
dom hexamers following the manufacturer’s instructions. The quantitative PCR was performed
using the SYBR1 Green Jumpstart™ Taq ReadyMix™ (Sigma-Aldrich1) or SensiMix™ (Bioline)
in a Chromo4 DNA engine (MRJ) with OpticonMonitor 3 (BioRad) software. A list of primers
used throughout this study is shown in S1 Table.
Flow Cytometric Analysis
Cells were fixed in ice cold 70% ethanol by incubation overnight at -20°C. Next day, the fixed
cells were washed three time in PBS and treated with 0.2μg/μl RNAse A (Sigma-Aldrich) in
PBS for 20min at 37°C. Cells were washed again in PBS and cellular DNA was stained with
50mg/ml propidium iodide (Millipore) diluted in PBS. Stained cells were quantified by FACS
(BD LSRII) and gated according to single-cell population and to DNA content representative
of the cell cycle.
Cell cycle separation by counterflow centrifugal elutriation
Cell cycle separation was conducted using an elutriation system with JE-5.0 elutriator rotor
(BeckmannCoulter Inc) equipped with Avanti J-26 XP centrifuge (BeckmannCoulter Inc)
and a pump. 2X10^8 cells were harvested and washed twice with Elutriation buffer (3.4mM
EDTA and 1% FBS in 1X PBS). In order to obtain a single cell suspension the cell pellet was
resuspended in 40ml Elutriation buffer and passed twice through an 18-gauge needle (25G)
syringe. Next, the sample was loaded into the pre-assembled elutriation chamber. Throughout
the elutriation process the centrifugewas maintained at a constant speed of 1700rpm at 4°C.
To obtain elutriation fractions, the flow rate of the elutriation buffer was increased from 8ml/
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min to 20ml/min by 1ml/min increments. Consecutively 200ml effluent volumes were collected
from the centrifuge for each flow rate and cells were pelleted by centrifugation. To assess the
quality of synchronization in each elutriated fractions, cells were stained PI followed by FACS
analysis. Based on the cell cycle profile similarity, elutriation fractions were further grouped
and categorised into 3 different fractions.
Chromatin immunoprecipitation
ChIP experiments were performed as describedpreviously [83], with fewmodifications.
Briefly, cells were fixed in 1% formaldehyde for 10 min at 37°C. Crosslinking was quenched by
adding glycine to a final concentration of 125mM for 5min at room temperature. Cell mono-
layers were incubated in cold swelling buffer (25 mMHEPES pH 7.9, 1.5 mMMgCl2, 10mM
KCl, 2.5% NP-40. Adjust pH to 7.9. Add freshly 0.5μl P8430 Protease inhibitor cocktail
(Sigma) and 5μl 0.1M PMSF in isopropanal per 1 ml of Swelling buffer) followed by scraping
and lysing using a Dounce homogenizer. The nuclear pellet was resuspended in cold sonication
buffer (50 mMHEPES pH 7.9, 140 mMNaCl, 1mM EDTA, 1% Triton X-100, 0.1% Na-deoxy-
cholate, 0.1% SDS. Adjust pH to 7.9. Add freshly 0.5μl P8430 Protease inhibitor cocktail
(Sigma) and 5μl 0.1M PMSF in isopropanol per 1 ml of Sonication buffer) and sonicated using
Biorupter (Diagenode) with high energy. Sheared chromatin was centrifuged twice at 15000g
for 15min and the supernatant was used for the immunoprecipitation. Immunoprecipitation
was performed by initially sonicating (low energy) the chromatin with antibody or no antibody
(negative control) using Biorupter (Diagenode) following an overnight incubation with Dyna-
beads Protein G (Invitrogen) on a rotating wheel at 4°C. Next day, protein G Dynabeads
bound to antibody–chromatin complexed was washed and DNA was purifiedwith iPure Kit
(Diagenode) following the manufacturer’s instructions. Antibodies used for ChIP were: H3
(Abcam, Ab1791), H3K9me3 (Millipore, 17–625) H3ac (Abcam, Ab47915), H3K4me3
(Abcam, Ab8580), H3K36me3 (Abcam, Ab9050), 20S β6 proteasome (Enzo Life,
BML-PW9000).
For the ChiP-seq analysis, the repeat element annotations for the mouse GRCm38 genome
build were downloaded from the RepeatMasker track from the UCSC genome browser web
site. GSM841627 and GSM1095381 sequencing reads (Catic et al., 2013) were aligned to repeat
genomes of several different repeat families using Bowtie 2 (v2.2.6; default parameters), and
hits were counted whereby multiple matches of a sequence are possible. The repeat genomes
were constructed by concatenating the sequences of each instance of the repeat into a single
repeat genome for that repeat family where individual repeats were separated by NNNNN to
prevent sequences frommapping over instance boundaries.
The minor satellite consensus sequence:
TTGTAGAACAGTGTATATCAATGAGTTACAATGAGAAACATGGAAAATGATAAAAACCA
CACTGTAGAACATATTAGATGAGTGAGTTACACTGAAAAACACATTCGTTGGAAACGGGAT,
was addedmanually to the Minor Satellite repeat genome.
RNA-FISH
RNA in situ hybridization (RNA-FISH) was performed using ViewRNA™ ISH Cell Assay kit
(Affymetrix, eBioscience) following the manufacturer’s instructions. The images were acquired
with a 63X oil-immersion lens using a LeicaMicrosystems SP5 confocal microscope. Analysis
of images was performed by Fiji Image J software. RNA probe: Major satellite RNA probe set
was designed and produced by eBioscience (Affymetrix) probe developers. This probe was
V00846—Mouse Satellite DNA sequence—type 1.
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Immunofluorescence
Cells were fixed with 4% PFA diluted in PBS containing 0.1% (v/v) Triton X100 for 15 min at
room temperature followed by three washes with PBS and permeabilisationwith 0.5% (v/v)
Triton X100 diluted in PBS for 30min at room temperature. Cells were washed again three
times in PBS and incubated in 20mM glycine dissolved in PBS for 30min at room temperature.
Subsequently, cells were blocked for 1h with PBS+ (1%BSA, 0.1% Casein, 0.02% Fish Skin Gel-
atin in 1X PBS. pH7.8–8) and incubated with primary antibody appropriately diluted in PBS
+ in a dark humidified chamber overnight at 4°C. Cells were washed again three times with
PBS and incubated in fluorochrome-conjugated (Alexa488 or Alexa568) secondary antibody
diluted to the required concentration in PBS for 1h at RT in a dark humidified chamber. Cells
were furtherwashed nine times with PBS and incubated for 15min with DAPI diluted in
1:1000 in PBS at room temperature before mounting them using Vectashield mounting
medium (Vector Laboratories). Images were acquired with LeicaMicrosystems SP5 confocal
microscope. Analysis of images was performed by Fiji Image J software. Antibodies used for
immunofluorescencewere: HP1α (Millipore, 05689), H3K9me3 (Millipore, 17–625)
ImagestreamX
0.5 million NIH3T3 cells were pelleted and washed twice in cold PBS++ (PBS containing 1mM
EDTA and 0.02% (w/v) Sodium azide) and resuspended in 100μl of 1μM DRAQ5 dissolved in
PBS++. 20000 events were collected at 40X magnification in bright field and the 658nm laser
wavelength with ImageStreamX (Amnis, Seattle, Washington). Raw data was quantitated using
the associated Image analysis software (IDEAS Amnis). After single cell and DRAQ5 fluores-
cence gating, the number of chromosome clusters per cell was determined by computing the
intensity of localizedDraq5 bright spots within the image that were greater than 2.75 pixels in
radius.
Western blot
Cells were lysed using RIPA buffer (50mMTris pH 8.0, 150mMNaCl, 0.5% Na-deoxycholate,
1% NP-40, 0.1% SDS. Freshly were added 0.5μl P8430 Protease inhibitor cocktail (Sigma) and
5μl 0.1M PMSF in isopropanol per 1 ml of RIFA buffer) and cell extract was cleared by centri-
fugation at 12 000g for 15min. The supernatant was collected and the protein concentration
was determined by Bradford dye colorimetric assay (Bio-rad), following the manufacturer’s
instructions. For protein denaturation, lysate samples with specific amounts of protein were
mixed with 6X Laemmli buffer (Alfa Aesar) followed by incubation at 100°C for 10min. 5μg of
protein was loaded on a SDS-PAGE gel and when electrophoresis was completed, the proteins
were electro-transferred from SDS-PAGE gel to pre-washed PVDFmembrane (GE Healthcare)
in the presence of Transfer buffer (25mMTris pH 8.3, 190mM glycine. Add freshly 20% (v/v)
methanol). The membrane was blocked in blocking buffer (0.1% (v/v) Tween 20, 5% non-fat
milk in PBS) for 1h at room temperature followed by incubation with the primary antibody in
blocking buffer on a rocking platform overnight at 4°C. After washing the membrane in PBS
supplemented with 1% Tween, the membrane was incubated with secondary antibody conju-
gated with Horse Radish Peroxidase (HRP) in blocking buffer for 1h at room temperature. The
presence of HRP on the membrane was then detected using ECL Plus Western Blotting Detec-
tion Reagents (GE Healthcare) using the manufacturer’s instructions.
Primary antibodies used were: HP1α (Millipore,MAB3446) was used at 1:500; α-tubulin
(Sigma, T5168) at 1:10000. SecondaryHRP-goat anti mouse antibody (Life Technologies,
G21040) was used at 1:20000.
Proteasome Inhibition Disrupts Heterochromatin
PLOS ONE | DOI:10.1371/journal.pone.0165873 November 2, 2016 12 / 18
Supporting Information
S1 Fig. Transcription of major satellite peaks in G1 phase and minor satellite in G2/M
phase of the cell cycle. (A) Cell fractions enriched at specific phases of the cell cycle, were
obtained by centrifugal elutriation. Top panel: representative images of the FACS profiles
after PI staining of non-elutriated cells and three different fractions of elutriated material. Bot-
tom graph: cell cycle distribution of each fraction shown as percentage of cells acquired. Error
bars = SEM of at least 3 biological replicates. (B) Expression of themajor satellite repeats
peaks in G1 phase of the cell cyclewhereasminor satellite repeats are expressed in G2/M
phase.The transcript levels of major and minor satellite repeats were analysed by q-RT-PCR
in all elutriated fractions of NIH3t3 cells as well as in non–elutriated cells. The relative expres-
sion was normalised against GAPDH and is shown relative to RNA levels obtained with not
elutriated cells. Error bars = SEM of at least 3 biological replicates.
(TIF)
S2 Fig. The effect of the proteasome inhibition on the distribution and levels of HP1α. (A)
Delocalisationof HP1α from chromocentres upon proteasome inhibition.NIH3T3 cells
were treated with 20μMMG132 for 8h and immunolabeled with HP1α antibody (green) and
co-stainedwith DAPI (blue). Scale bar 10μm. (B) Total HP1α protein levels remain similar
upon proteasome inhibition. NIH3T3 cells were treated with 20μMMG132 for 2h, 4h and 8h.
Total cell lysate was probed with antibody against HP1α (~22 kDa) and α-tubulin (~55kDa)
that served as a loading control.
(TIF)
S1 Table. List of primers used throughout this study.
(TIF)
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